• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    R

    Red Cross War Memorial Children''s Hospital,Western Cape Department of Health

    EST. 1956
    1,091论文总数
    2.2万引用总数

    Red Cross War Memorial Children's Hospital in Cape Town, South Africa was opened in 1956 through public subscription as a memorial to soldiers lost in the Second World War. The suggestion that the memorial take the form of a children's hospital was proposed by Vyvyan U.T. Watson. Mr Watson, a prominent businessman, had lost his first born and only son, Peter Tennant Watson, at about four years old, to an outbreak of diphtheria in Cape Town. Mr Watson was a major force in steering the organization of the building of the hospital. The Peter Pan statue on the hospital grounds, sculpted by Ivan Mitford-Barberton, was donated by Mr Watson and his wife, Gwendolyn. Mr Watson was later President of the South African Red Cross Society. It is one of two dedicated children's public hospitals in sub-Saharan Africa, and one of only a few dedicated children's hospitals in the Southern hemisphere.The hospital has academic links to the University of Cape Town's School of Child and Adolescent Health, the University of the Western Cape Dental School and the University of Stellenbosch; it is regarded as South Africa's leading centre for post-graduate specialist paediatric medical and surgical training..

    论文量&引用量时间轴

    机构学者

    论文(1091)

    年份
    起
    –
    止
    排序
    13 is This Autism, Now What? Multidisciplinary Team Outreach Initiatives Within the Resource Constrained Health System in Cape Town, South Africa
    Sashmi Moodley, Mereille Pursad, Lezanne De Villiers, Gill Schermbrucker, Chanel Baumgarten, Kirsten A Donald
    20263 Is this autism, now what Multidisciplinary team outreach initiatives within the resource constrain...(2026)
    引用
    AI阅读
    加入学术空间
    2Peritoneal Dialysis Catheter Type for Acute Kidney Injury and Clinical Outcomes: How Rigid Should We Be?
    Mignon McCulloch,Danielle E Soranno,Arpana Iyengar
    2026Peritoneal dialysis international journal of the International Society for Peritoneal Dialysis(2026)
    引用
    AI阅读
    加入学术空间
    3Acceptability, Feasibility, Quality of Life and Diabetes Distress Score Outcomes: A Pragmatic Randomised Clinical Trial on Continuous Glucose Monitoring for People with Type 1 Diabetes
    Elena Marbán-Castro, Lorrein Muhwava, Sarah Girdwood,Tanja Kemp, Johanè Freitas, Yvonne Kamau, Michael Otieno, Dorcas Akach, Alba Morató, Sergi Sanz, Vincent Fiechter, Berra Erkosar,

    Introduction: Continuous glucose monitoring (CGM) offers an advancement over traditional self-monitoring of blood glucose (SMBG) for people living with type 1 diabetes (T1D). However, evidence on the acceptability and feasibility of different CGM use cases in African populations remains limited. Methods: This was a pragmatic three-arm, randomised controlled trial on CGM conducted among people living with T1D in three public healthcare clinics in South Africa. Participants were assigned to Arm 1 (continuous CGM), Arm 2 (periodic CGM), or Arm 3 (SMBG). Diabetes education was provided at all study visits. Feasibility was assessed by adherence to CGM use and through the Glucose Monitoring Satisfaction Survey (GMSS). Diabetes distress was measured by the Diabetes Distress Scale (DDS), health-related quality of life (HRQoL) by the EQ-5D scales, and acceptability using the Theoretical Framework of Acceptability (TFA). Surveys were collected on paper and transferred to OpenClinica. Analyses were performed in R. The trial was registered in the Clinical Trials Registry ([NCT05944718][1]) on July 13, 2023. Results: A total of 83 participants were included in Arm 1, 85 in Arm 2, and 80 in Arm 3. CGM mean active time was 55% in Arm 1 versus 69% in Arm 2. The proportion of participants meeting the ≥70% active time threshold was higher in Arm 2 (52%) than in Arm 1 (34%). Diabetes' distress declined across arms during the intervention period, with no significant difference between arms; distress increased slightly six months post-intervention but remained below baseline. At 6 months, glucose monitoring satisfaction was significantly higher in both CGM arms than in the SMBG arm, and satisfaction increased over time in CGM arms. Health-related quality of life remained stable across arms during the intervention period with no significant difference between arms. High acceptability was observed in both CGM arms, with higher ratings in the periodic arm. Conclusions: CGM was acceptable to people living with type 1 diabetes and feasible to use in public-sector clinics in South Africa, with high acceptability under continuous and periodic use. Health-related quality of life remained stable across arms, and diabetes-related distress declined, during the intervention period, across arms. Glucose monitoring satisfaction rose significantly in both CGM arms compared to SMBG. Periodic CGM might be a promising and potentially more scalable option than continuous use for public-sector care. ### Competing Interest Statement Abbot sponsored registration (Prof Karsas and Prof Rheeder) for the SEMDSA (Society for Endocrinoloy, Metabolism and Diabetes of South Africa) congress in Durban 2025. Prof JA Dave has received honoraria from Abbot for continuing medical education activities on continuous glucose monitoring. ### Clinical Trial https://clinicaltrials.gov/study/[NCT05944718][1] ### Clinical Protocols ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The protocol was approved by the Faculty of Health Sciences Research Ethics Committee at the University of Pretoria (330/2023) and the Human Research Ethics Committee at the University of Cape Town (HREC REF 558/2023). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes De-identified individual participant-level?data?is available at https://zenodo.org/records/21531500 .?Study protocol?was already published at:?https://link.springer.com/article/10.1186/s13063-024-08132-7.? [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT05944718&atom=%2Fmedrxiv%2Fearly%2F2026%2F08%2F31%2F2026.08.26.26361479.atom

    2026
    引用
    AI阅读
    加入学术空间
    4Outcomes of Truncus Arteriosus Repair from International Quality Improvement Collaborative Registry
    Yen Chuan Chen, Sivakumar Sivalingam, Maria Desocio, Le-Thanh Dinh, Phuong-Chau Nguyen, Raman K Kumar, Brijesh Kottayil, Andre Brooks, Liesl Zuhlke, Marcos Aurelio Barboza de Oliveira, Andreia Consuelo de Oliveira Teles,Kimberlee Gauvreau,

    Background: Truncus arteriosus (TA) is a rare, high-risk congenital heart lesion requiring early surgical repair. Most contemporary outcome data come from single-centre or high-income cohorts, limiting generalizability to mixed-resource settings where many affected children receive care. Objectives: To describe in-hospital mortality and major infection after TA repair in a global quality-improvement registry and to evaluate associations of patient characteristics and institutional volume with these outcomes. Methods: Children younger than 18 years undergoing primary TA repair, with or without interrupted aortic arch (IAA), between 2010 and 2024 were identified from audited centres in the International Quality Improvement Collaborative (IQIC) registry. The primary outcome was in-hospital mortality. Secondary outcomes included any major postoperative infection. Hierarchical logistic regression with centre-level random intercepts was used. Primary multivariable models were restricted to isolated TA; TA-IAA was analysed separately. Results: The cohort included 812 patients from 58 centres in 21 countries; 722 (88.9%) had isolated TA and 90 (11.1%) had TA-IAA. In isolated TA, median age at repair was 61 days (interquartile range 30-152), and 11.5% underwent repair at ≥1 year. Median institutional annual volume was 1.0 repair per year (range 0-9.4). In-hospital mortality was 18.4%, and major infection occurred in 17.5%. Crude in-hospital mortality was 16.7% (21/126) among those with major infection and 18.8% (112/596) among those without; in multivariable analysis, major infection was not independently associated with mortality (adjusted odds ratio [aOR] 0.70, 95% confidence interval [CI] 0.39-1.27; p=0.25). Independent predictors of mortality were age at surgery ≤30 days (aOR 2.12, 95% CI 1.45-3.10; p<0.001), preoperative oxygen saturation <80% versus 90-100% (aOR 2.16, 95% CI 1.09-4.29; p=0.028), any major non-cardiac medical illness (aOR 1.61, 95% CI 1.02-2.56; p=0.042), and institutional volume <1.0 versus ≥5.0 repairs per year (aOR 2.55, 95% CI 1.22-5.30; p=0.013). In the TA-IAA cohort (n=90), in-hospital mortality was 33.3%, and age ≤30 days was the main independent predictor (aOR 4.30, 95% CI 1.71-10.8; p=0.002). Conclusions: In this global mixed-resource cohort, TA repair was associated with high in-hospital mortality and frequent major infection, particularly in younger and more vulnerable patients treated at lower-volume centres. Major infection did not independently predict in-hospital mortality. These findings support early referral and repair, use of simple preoperative variables (age, oxygen saturation, comorbidity, centre volume) to inform risk-aware decision-making, and targeted quality-improvement strategies focused on infection prevention and strengthening lesion-specific institutional experience.

    2026Circulation(2026)
    引用
    AI阅读
    加入学术空间
    5External Validation of Pediatric Pneumonia and Bronchiolitis Risk Scores to Predict Mortality in Children Hospitalized in Kenya: A Retrospective Cohort Study.
    Becky Gordon,Joyce U Nyiro,Harish Nair,Zakariya Sheikh, Esther Katama,Charles N Agoti, Ruonan Pei,Heather Zar,Ting Shi

    BACKGROUND:Acute lower respiratory tract infections (ALRIs) are a leading cause of pediatric mortality in low- and middle-income countries. In recent years, substantial research has been done to enhance risk stratification of children presenting with ALRIs, in a bid to improve health outcomes in resource-limited settings. We sought to analyze the performance of several pediatric ALRI risk scores in the prediction of mortality among children hospitalized with ALRIs in Kenya. METHODS:We retrospectively analyzed the data of 2182 children aged 2-24 months who were admitted to Kilifi County Referral Hospital, Kenya with severe ALRIs between January 2015 and December 2024. We evaluated the performance of 6 ALRI risk scores (RISC [HIV-negative], mRISC, RISC-Malawi, PERCH, PREPARE, and ReSVinet) in this population. Additionally, we created and evaluated a modified version of the ReSVinet score by including nutrition status. Discrimination was assessed using the area under the receiver operating characteristic curve (AUROC). RESULTS:The mid-upper arm circumference (MUAC) version of the RISC-Malawi score showed the highest discrimination for the outcome of in-hospital mortality (AUROC, 0.83; 95% confidence interval, .79-.86), whilst all other scores showed acceptable discrimination (AUROC, 0.70-0.79). The modification of ReSVinet to include nutrition status significantly improved its AUROC from 0.72 to 0.79. CONCLUSIONS:All risk scores showed at least fair performance in the prediction of in-hospital mortality within our dataset. The RISC-Malawi (MUAC) score appears to be the most promising candidate for future implementation; however, further research is needed to evaluate the calibration, feasibility, and clinical utility of these scores.

    2026The Journal of infectious diseases(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1091 篇论文

    合作机构(100)

    开普敦大学合作论文 287
    Groote Schuur Hospital,Western Cape Department of Health合作论文 47
    斯泰伦博斯大学合作论文 26
    瓦特沃斯兰德大学合作论文 14
    普勒托利亚大学合作论文 12
    夸祖鲁 - 纳塔尔大学合作论文 10
    西澳大利亚大学合作论文 9
    多伦多大学合作论文 7
    昆士兰大学合作论文 7
    Erasmus MC - Sophia Children’s Hospital合作论文 7

    机构统计